The inhalation market focuses on delivering medications directly to the lungs through inhalable forms, such as metered-dose inhalers (MDIs), dry powder inhalers (DPIs), soft-mist inhalers (SMIs) and nebulizers. It is driven primarily by the rising prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and other lung-related and systemic illnesses. There is a growing emphasis on patient-friendly and environmentally sustainable devices, such as propellant-free and digital inhalers.

H&T Presspart is a leader in the development and manufacturing of components and devices in Inhalation. Our in-house analytical and development capabilities provide a full service offering to accelerate the pathway to market.

The parenteral market involves medications administered via injections, such as intravenous (IV), intramuscular (IM), and subcutaneous (SC) methods. This market is driven by the growing need for biologics, vaccines, and complex pharmaceuticals that require precise and rapid delivery into the bloodstream for maximum efficacy. It encompasses a wide range of products, including prefilled syringes (PFS), vials, ampoules, and advanced delivery systems like autoinjectors and wearable devices.

H&T Presspart develops and industrialises advanced parenteral drug delivery devices such as autoinjectors. In 2025, our Vytal ready-to use (RTU) Snap-fit Container Closure System (CCS) system will be launched to the market.

As the aging population grows, the prevalence of ocular conditions like glaucoma, dry eye disease, macular degeneration, and diabetic retinopathy is on the rise, making the ocular drug delivery market a significant growth area within the pharmaceutical sector. It includes a range of delivery formats, including eye drops, ocular implants, and innovative sustained-release systems designed to overcome the eye’s natural barriers and improve drug bioavailability.

H&T Presspart has collaborated with several companies in the specialized design and manufacture of ocular implanters, positioning us well to assist other pharmaceutical companies aiming to introduce ocular devices to the market.

The medical diagnostics market encompasses a diverse array of devices and technologies used to identify diseases or conditions in patients. This market is set for significant growth, fueled by technological advancements, a rising demand for early disease detection, and an increasing global need for healthcare services.

At H&T Presspart, we produce various devices for in-vitro diagnostic testing, including blood cards for blood group typing and antibody investigation, as well as a testing device for monitoring calprotectin levels in patients.